Pages

Saturday, June 1, 2019

Communications with stakeholders concerning access to compounded oral oxitriptan for patients with tetrahydrobiopterin deficiency

https://www.fda.gov/drugs/drug-safety-and-availability/communications-stakeholders-concerning-access-compounded-oral-oxitriptan-patients

No comments:

Post a Comment